Johnson & Johnson on Tuesday reported quarterly results that beat analysts’ estimates on strong demand for cancer drug Darzalex and its COVID-19 vaccine, even as the company cut its full-year adjusted profit forecast due to a stronger dollar. J&J joins other major U.S. multinationals with sizeable international operations, including Microsoft Corp and IBM, in warning…